Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?

Am J Dermatopathol. 2022 Jan 1;44(1):80-82. doi: 10.1097/DAD.0000000000002104.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • COVID-19 / prevention & control*
  • ChAdOx1 nCoV-19 / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Vasculitis / etiology*

Substances

  • ChAdOx1 nCoV-19

Supplementary concepts

  • Vasculitis, Lymphocytic, Cutaneous Small Vessel